Cargando…

Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways

BACKGROUND: Polycystic Kidney Disease is characterized by the formation of large fluid-filled cysts that eventually destroy the renal parenchyma leading to end-stage renal failure. Although remarkable progress has been made in understanding the pathologic mechanism of the disease, the precise orches...

Descripción completa

Detalles Bibliográficos
Autores principales: Koupepidou, Panayiota, Felekkis, Kyriacos N, Kränzlin, Bettina, Sticht, Carsten, Gretz, Norbert, Deltas, Constantinos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936873/
https://www.ncbi.nlm.nih.gov/pubmed/20813037
http://dx.doi.org/10.1186/1471-2369-11-23
_version_ 1782186523401125888
author Koupepidou, Panayiota
Felekkis, Kyriacos N
Kränzlin, Bettina
Sticht, Carsten
Gretz, Norbert
Deltas, Constantinos
author_facet Koupepidou, Panayiota
Felekkis, Kyriacos N
Kränzlin, Bettina
Sticht, Carsten
Gretz, Norbert
Deltas, Constantinos
author_sort Koupepidou, Panayiota
collection PubMed
description BACKGROUND: Polycystic Kidney Disease is characterized by the formation of large fluid-filled cysts that eventually destroy the renal parenchyma leading to end-stage renal failure. Although remarkable progress has been made in understanding the pathologic mechanism of the disease, the precise orchestration of the early events leading to cyst formation is still unclear. Abnormal cellular proliferation was traditionally considered to be one of the primary irregularities leading to cyst initiation and growth. Consequently, many therapeutic interventions have focused on targeting this abnormal proliferation, and some have even progressed to clinical trials. However, the role of proliferation in cyst development was primarily examined at stages where cysts are already visible in the kidneys and therefore at later stages of disease development. METHODS: In this study we focused on the cystic phenotype since birth in an attempt to clarify the temporal contribution of cellular proliferation in cyst development. Using a PKD2 transgenic rat model (PKD2 (1-703)) of different ages (0-60 days after birth) we performed gene expression profiling and phenotype analysis by measuring various kidney parameters. RESULTS: Phenotype analysis demonstrated that renal cysts appear immediately after birth in the PKD2 transgenic rat model (PKD2 (1-703)). On the other hand, abnormal proliferation occurs at later stages of the disease as identified by gene expression profiling. Interestingly, other pathways appear to be deregulated at early stages of the disease in this PKD model. Specifically, gene expression analysis demonstrated that at day 0 the RAS system is involved. This is altered at day 6, when Wnt signaling and focal adhesion pathways are affected. However, at and after 24 days, proliferation, apoptosis, altered ECM signaling and many other factors become involved. CONCLUSIONS: Our data suggest that cystogenesis precedes deregulation of proliferation-related pathways, suggesting that proliferation abnormalities may contribute in cyst growth rather than cyst formation.
format Text
id pubmed-2936873
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29368732010-09-11 Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways Koupepidou, Panayiota Felekkis, Kyriacos N Kränzlin, Bettina Sticht, Carsten Gretz, Norbert Deltas, Constantinos BMC Nephrol Research Article BACKGROUND: Polycystic Kidney Disease is characterized by the formation of large fluid-filled cysts that eventually destroy the renal parenchyma leading to end-stage renal failure. Although remarkable progress has been made in understanding the pathologic mechanism of the disease, the precise orchestration of the early events leading to cyst formation is still unclear. Abnormal cellular proliferation was traditionally considered to be one of the primary irregularities leading to cyst initiation and growth. Consequently, many therapeutic interventions have focused on targeting this abnormal proliferation, and some have even progressed to clinical trials. However, the role of proliferation in cyst development was primarily examined at stages where cysts are already visible in the kidneys and therefore at later stages of disease development. METHODS: In this study we focused on the cystic phenotype since birth in an attempt to clarify the temporal contribution of cellular proliferation in cyst development. Using a PKD2 transgenic rat model (PKD2 (1-703)) of different ages (0-60 days after birth) we performed gene expression profiling and phenotype analysis by measuring various kidney parameters. RESULTS: Phenotype analysis demonstrated that renal cysts appear immediately after birth in the PKD2 transgenic rat model (PKD2 (1-703)). On the other hand, abnormal proliferation occurs at later stages of the disease as identified by gene expression profiling. Interestingly, other pathways appear to be deregulated at early stages of the disease in this PKD model. Specifically, gene expression analysis demonstrated that at day 0 the RAS system is involved. This is altered at day 6, when Wnt signaling and focal adhesion pathways are affected. However, at and after 24 days, proliferation, apoptosis, altered ECM signaling and many other factors become involved. CONCLUSIONS: Our data suggest that cystogenesis precedes deregulation of proliferation-related pathways, suggesting that proliferation abnormalities may contribute in cyst growth rather than cyst formation. BioMed Central 2010-09-02 /pmc/articles/PMC2936873/ /pubmed/20813037 http://dx.doi.org/10.1186/1471-2369-11-23 Text en Copyright ©2010 Koupepidou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Koupepidou, Panayiota
Felekkis, Kyriacos N
Kränzlin, Bettina
Sticht, Carsten
Gretz, Norbert
Deltas, Constantinos
Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways
title Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways
title_full Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways
title_fullStr Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways
title_full_unstemmed Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways
title_short Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways
title_sort cyst formation in the pkd2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936873/
https://www.ncbi.nlm.nih.gov/pubmed/20813037
http://dx.doi.org/10.1186/1471-2369-11-23
work_keys_str_mv AT koupepidoupanayiota cystformationinthepkd21703transgenicratprecedesderegulationofproliferationrelatedpathways
AT felekkiskyriacosn cystformationinthepkd21703transgenicratprecedesderegulationofproliferationrelatedpathways
AT kranzlinbettina cystformationinthepkd21703transgenicratprecedesderegulationofproliferationrelatedpathways
AT stichtcarsten cystformationinthepkd21703transgenicratprecedesderegulationofproliferationrelatedpathways
AT gretznorbert cystformationinthepkd21703transgenicratprecedesderegulationofproliferationrelatedpathways
AT deltasconstantinos cystformationinthepkd21703transgenicratprecedesderegulationofproliferationrelatedpathways